Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

Lisdexamfetamine dimesylate (LDX) is the first prodrug stimulant used for the treatment of attention-deficit/hyperactivity disorder (ADHD) dosed once daily. Due to its long-acting properties, LDX remains pharmacologically inactive until an enzymatic process predominantly associated with red blood ce...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cent Nerv Syst Dis
Autors principals: Najib, Jadwiga, Wimer, Dexter, Zeng, Julie, Lam, Kristina W, Romanyak, Natalya, Paige Morgan, Eva, Thadavila, Anu
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2017
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5571766/
https://ncbi.nlm.nih.gov/pubmed/28855799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179573517728090
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars